NAM
REGN icon

NorthCrest Asset Manangement’s Regeneron Pharmaceuticals REGN Stock Holding History

NorthCrest Asset Manangement’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.65M Sell
9,963
-61
-0.6% -$41.5K 0.17% 123
2026
Q1 		$7.64M Sell
10,024
-2,758
-22% -$2.11M 0.24% 108
2025
Q4 		$9.76M Buy
12,782
+886
+7% +$602K 0.22% 108
2025
Q3 		$6.94M Buy
11,896
+342
+3% +$193K 0.17% 118
2025
Q2 		$6.32M Sell
11,554
-349
-3% -$195K 0.17% 121
2025
Q1 		$7.55M Buy
11,903
+557
+5% +$383K 0.23% 109
2024
Q4 		$8.08M Buy
11,346
+270
+2% +$227K 0.24% 103
2024
Q3 		$11.6M Buy
11,076
+271
+3% +$302K 0.35% 83
2024
Q2 		$11.4M Buy
10,805
+256
+2% +$248K 0.38% 81
2024
Q1 		$10.2M Buy
10,549
+143
+1% +$136K 0.35% 88
2023
Q4 		$9.14M Sell
10,406
-20
-0.2% -$16.5K 0.35% 88
2023
Q3 		$8.58M Sell
10,426
-21
-0.2% -$16.5K 0.35% 91
2023
Q2 		$7.51M Buy
10,447
+132
+1% +$102K 0.3% 106
2023
Q1 		$8.48M Buy
10,315
+516
+5% +$389K 0.35% 96
2022
Q4 		$7.07M Sell
9,799
-609
-6% -$449K 0.4% 89
2022
Q3 		$7.17M Buy
10,408
+88
+0.9% +$55.4K 0.39% 94
2022
Q2 		$6.1M Sell
10,320
-151
-1% -$98.2K 0.31% 109
2022
Q1 		$7.31M Buy
10,471
+582
+6% +$368K 0.35% 101
2021
Q4 		$6.25M Buy
+9,889
New +$6.08M 0.34% 92

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

NorthCrest Asset Manangement's REGN Position: Q2 2026 in Review

NorthCrest Asset Manangement reduced its Regeneron Pharmaceuticals (REGN) stake by 0.61% in Q2 2026, selling an estimated $41.5K and leaving 9,963 shares worth $6.65M. The position accounts for 0.17% of the portfolio, ranked #123.

NorthCrest Asset Manangement first reported a position in REGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $11.6M in Q3 2024. 729 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • NorthCrest Asset Manangement held 9,963 shares of Regeneron Pharmaceuticals worth $6.65M as of Q2 2026.
  • NorthCrest Asset Manangement sold 61 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $41.5K.
  • Regeneron Pharmaceuticals made up 0.17% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #123 holding.
  • NorthCrest Asset Manangement first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • NorthCrest Asset Manangement's Regeneron Pharmaceuticals position peaked at $11.6M in Q3 2024.
  • 729 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.